347 results on '"Zietman, A.L."'
Search Results
2. Prospective Validation of Single Nucleotide Polymorphisms as Predictors of Gastrointestinal, Genitourinary, and Sexual Patient-Reported Outcomes Following Radiotherapy for Prostate Cancer
3. Prognostic Significance of Pretreatment Immune Cell Infiltration in Muscle Invasive Bladder Cancer Treated with Definitive Chemoradiation: Analysis of NRG RTOG 0524 and 0712
4. Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): A Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer
5. Dosimetric Analysis of Radiation Treatment Plans Based on a Deep Learning Auto Contouring Model for Patients with Localized Prostate Cancer
6. Radiation Therapy for Stage IIA/B Seminoma: Modeling Secondary Cancer Risk for Protons and VMAT vs. 3D Photons
7. Multi-Institutional Matched Comparison of Radical Cystectomy to Trimodality Therapy for Muscle Invasive Bladder Cancer (MIBC)
8. Recent Trends of “Manels” and Gender Representation among Panelists at North American Annual Radiation Oncology Meetings
9. Qualitative and Quantitative Analysis of a Deep Learning Auto Contouring Model for Radiotherapy in Localized Prostate Cancer
10. Mixed Methods Evaluation of a Targeted One-Week Virtual Radiation Oncology Intensive Shadowing Experience for Medical Students Underrepresented in Medicine: Mentor's Perspective
11. Impact of the COVID-19 Pandemic on Prostate Cancer Radiotherapy Practice Patterns: A Northeast Regional Longitudinal Survey Study
12. Metastasis-Free Survival, but Not Biochemical Failure, is a Strong Surrogate Endpoint for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601
13. Bladder Preservation with Twice-Daily Radiation plus 5-Flourouracil/Cisplatin or Daily Radiation plus Gemcitabine for MIBC – Updated Results of NRG/RTOG 0712: A Randomized Phase 2 Trial
14. Quantitative and Qualitative Evaluation of a Deep Learning Auto Contouring Model for Prostate Cancer Patients With Hydrogel Spacer
15. External Validation of Early Quality of Life (QOL) Declines Correlated with Late QOL after Intensity Modulated, Low Dose Rate Brachytherapy, or Stereotactic Radiation for Prostate Cancer within a Prospective Trial
16. The Impact of Persistently Elevated PSA after Prostatectomy in Men with Recurrent Prostate Cancer in NRG Oncology/RTOG 9601
17. Two Years of Anti-Androgen Treatment Increases Other-Cause Mortality in Men Receiving Early Salvage Radiotherapy: A Secondary Analysis of the NRG Oncology/RTOG 9601 Randomized Phase III Trial
18. Prospective Validation of Single Nucleotide Polymorphisms as Predictors of Rectal Toxicity Following Radiation Therapy for Prostate Cancer
19. Integrated Gene Expression Score in Circulating Tumor Cells to Predict Treatment Response in Muscle-Invasive Bladder Cancer
20. Impact of Post-Prostatectomy Prostate Specific Antigen (PSA) Kinetics on Outcomes of Salvage Radiotherapy
21. Neoadjuvant Androgen Suppression and External Beam Radiation Therapy
22. Radiation, Chemotherapy and Transurethral Surgery: An Organ-Sparing Alternative to the Radical Cystectomy
23. 10-Year Outcome for Men With Localized Prostate Cancer Treated With External Radiation Therapy:: Results of a Cohort Study
24. Views on Global Health Among Radiation Oncology Residency Program Directors: A Knowledge, Attitudes, and Practices Survey
25. Can Demographic Factors or Academic Metrics of Red Journal Reviewers Predict the Quality of their Reviews?
26. Prospective Evaluation of a Digital RNA Circulating Tumor Cell Signature in Localized Prostate Cancer
27. Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer
28. LATE NORMAL TISSUE SEQUELAE IN THE SECOND DECADE AFTER HIGH DOSE RADIATION THERAPY WITH COMBINED PHOTONS AND CONFORMAL PROTONS FOR LOCALLY ADVANCED PROSTATE CANCER
29. The value of external beam radiation in node positive prostate cancer: a multivariate analysis
30. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder
31. Radiation therapy in the management of early stage Hodgkin's disease presenting in later life
32. Too Big to Fail? The Current Status of Proton Therapy in the USA
33. Selective Bladder Preservation with Twice-Daily Radiation Plus 5-Flourouracil/Cisplatin or Daily Radiation Plus Gemcitabine for Patients with Muscle Invasive Bladder Cancer—Primary Results of NRG/RTOG 0712: A Randomized Phase 2 Multicenter Trial
34. Outcomes and Tolerability of Selective Bladder Preservation by Combined Modality Therapy for Invasive Bladder Cancer in Elderly Patients
35. The Impact of MRE11 in Nuclear to Cytoplasmic Ratio on Outcomes in Muscle Invasive Bladder Cancer: an Analysis of NRG/RTOG 8802, 8903, 9506, 9706, 9906, and 0233.
36. Multi-institutional Outcomes of Postprostatectomy Adjuvant Versus Early Salvage Radiation Therapy in Prostate Cancer Patients With Adverse Pathologic Features
37. Can Gender Predict Differences in Behavior, Manuscript Ratings, and Quality of Reviews Among Red Journal Reviewers?
38. Clinical Outcomes of Combined Modality Bladder-Sparing Therapy for Patients With Histologic Variants of Bladder Cancer
39. Clinical Needs Assessment for Sexual Health Among Cancer Patients Receiving Pelvic Radiation
40. The Natural History of Nonmuscle-Invasive Bladder Cancer Recurrences After Complete Response to Combined-Modality Organ-Preserving Therapy for Muscle-Invasive Bladder Cancer
41. Dosimetric Validation of Robotic Prostate SBRT With Simultaneous Integrated Dose Escalation to Dominant Intraprostatic Lesion Using a Magnetic Resonance–Based 3D-Printed Prostate Model in an Anthropomorphic Pelvis Phantom
42. Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-Term Results of a Large Institutional Experience
43. Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA
44. Long-term Results of Early Salvage Versus Adjuvant Postprostatectomy Radiation: A Large Institutional Experience
45. Protons for Prostate: Seeking Benefit via Anterior Beam Angles
46. Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer
47. Long-term Outcomes After Bladder-Preserving Combined Modality Therapy for Patients With Muscle-Invasive Bladder Cancer
48. Early Quality of Life (QOL) Declines Correlate With Later QOL After Intensity Modulated Radiation Therapy, Low-Dose-Rate Brachytherapy, or Stereotactic Radiation for Prostate Cancer
49. Comparative Effectiveness Analysis of Patient-Reported Quality of Life (QOL) After Stereotactic Body Radiation Therapy as Compared to Intensity Modulated Radiation Therapy or Low-Dose-Rate Brachytherapy up to 2 Years After Treatment
50. Outcomes With Full Dose Re-irradiation With Curative Intent for Secondary Anorectal Cancers Following Prostatic Radiation Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.